34,392 results on '"IDIOPATHIC pulmonary fibrosis"'
Search Results
2. Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE)
3. To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF
4. A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
5. A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
6. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
7. To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients with IPF
8. Real-life-persistence to Antifibrotic Treatments (REPEAT)
9. A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis
10. A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
11. A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550 (FIBRONEER™-ON)
12. A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
13. Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
14. Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
15. A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. (ASPIRE)
16. Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
17. Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
18. Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
19. Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
20. Study Evaluating INS018_055 Administered Orally to Subjects with Idiopathic Pulmonary Fibrosis (IPF)
21. Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
22. Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) (MEDICO-LIBS)
23. Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE-IPF)
24. Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
25. Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
26. Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions
27. Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
28. Atezolizumab for Idiopathic Pulmonary Fibrosis
29. Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
30. Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
31. Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis (ART-IPF)
32. The Assessment of Nutritional Status of Patients With IPF
33. Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF
34. The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis (Radiomics)
35. Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation. (REACT)
36. Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
37. A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
38. Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON)
39. A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib
40. Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry (IPF/ILD-PRO)
41. Cough Reduction in IPF With Nalbuphine ER (CORAL)
42. Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
43. Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER
44. Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
45. Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis (GENESI)
46. A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
47. Anlotinib Capsules in the Treatment for IPF/PF-ILDs
48. Effects of Pulmonary Diseases and Their Treatment on Cardiac Function
49. The Effect of N115 on Coughing in IPF Patients
50. Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.